Spero Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Spero Therapeutics, Inc. (SPRO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$849.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- Spero Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$654.00K.
- Spero Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$195.00K.
- Spero Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $386.00K.
- Spero Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$47.00K.
- Spero Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$277.00K.
- Spero Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$2.27M, a 383.73% decline from fiscal 2023.
- Spero Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $799.00K.
- Spero Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$5.24M, a 286.68% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$654.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$849.00K 10-Q · filed 2026-08-12 | -$463.00K derived: sum of 3 quarters · filed 2026-08-12 | -$510.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$195.00K 10-Q · filed 2026-05-13 | $191.00K derived: sum of 2 quarters · filed 2026-05-13 | $144.00K derived: sum of 3 quarters · filed 2026-05-13 | -$109.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $339.00K derived: sum of 2 quarters · filed 2026-03-26 | $86.00K derived: sum of 3 quarters · filed 2026-08-12 | -$277.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$300.00K derived: sum of 2 quarters · filed 2026-08-12 | -$663.00K 10-Q · filed 2025-11-13 | -$807.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$253.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$616.00K 10-Q · filed 2026-08-12 | -$760.00K derived: sum of 3 quarters · filed 2026-08-12 | -$1.90M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$363.00K 10-Q · filed 2026-05-13 | -$507.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.65M derived: sum of 3 quarters · filed 2026-05-13 | -$2.12M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$1.28M derived: sum of 2 quarters · filed 2026-03-26 | -$1.76M derived: sum of 3 quarters · filed 2026-03-26 | -$2.27M 10-K · filed 2026-03-26 |
| 2024-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.61M derived: sum of 2 quarters · filed 2025-11-13 | -$2.12M 10-Q · filed 2025-11-13 | -$3.35M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$982.00K 10-Q · filed 2025-08-12 | -$2.21M derived: sum of 3 quarters · filed 2025-08-12 | -$5.38M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$510.00K 10-Q · filed 2025-05-13 | -$1.74M derived: sum of 2 quarters · filed 2025-05-13 | -$4.90M derived: sum of 3 quarters · filed 2025-05-13 | $125.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$4.39M derived: sum of 2 quarters · filed 2025-03-27 | $635.00K derived: sum of 3 quarters · filed 2025-03-27 | $799.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$3.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.86M derived: sum of 2 quarters · filed 2024-11-14 | $2.03M 10-Q · filed 2024-11-14 | $3.92M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $5.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $5.19M 10-Q · filed 2024-08-05 | $7.08M derived: sum of 3 quarters · filed 2024-08-05 | $3.60M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $164.00K 10-Q · filed 2024-05-15 | $2.06M derived: sum of 2 quarters · filed 2024-05-15 | -$1.43M derived: sum of 3 quarters · filed 2024-05-15 | -$5.05M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$1.60M derived: sum of 2 quarters · filed 2024-03-13 | -$5.21M derived: sum of 3 quarters · filed 2024-03-13 | -$5.24M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$7.10M derived: sum of 2 quarters · filed 2023-11-13 | -$7.13M 10-Q · filed 2023-11-13 | -$1.57M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$3.65M 10-Q · filed 2023-08-10 | $1.92M derived: sum of 3 quarters · filed 2023-08-10 | $420.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$31.00K 10-Q · filed 2023-05-11 | $5.54M derived: sum of 2 quarters · filed 2023-05-11 | $4.04M derived: sum of 3 quarters · filed 2023-05-11 | $3.65M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $5.57M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $4.07M derived: sum of 2 quarters · filed 2023-03-30 | $3.68M derived: sum of 3 quarters · filed 2023-03-30 | $2.81M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.89M derived: sum of 2 quarters · filed 2022-11-14 | -$2.76M 10-Q · filed 2022-11-14 | -$3.99M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$389.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$1.26M 10-Q · filed 2022-08-10 | -$2.49M derived: sum of 3 quarters · filed 2022-08-10 | -$4.35M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$869.00K 10-Q · filed 2022-05-16 | -$2.10M derived: sum of 2 quarters · filed 2022-05-16 | -$3.96M derived: sum of 3 quarters · filed 2022-05-16 | -$489.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$3.09M derived: sum of 2 quarters · filed 2022-03-31 | $380.00K derived: sum of 3 quarters · filed 2022-03-31 | $1.24M 10-K · filed 2022-03-31 |
| 2020-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.61M derived: sum of 2 quarters · filed 2021-11-10 | $2.47M 10-Q · filed 2021-11-10 | $3.62M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $3.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.33M 10-Q · filed 2021-08-05 | $5.48M derived: sum of 3 quarters · filed 2021-08-05 | $2.87M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $860.00K 10-Q · filed 2021-05-06 | $2.01M derived: sum of 2 quarters · filed 2021-05-06 | -$604.00K derived: sum of 3 quarters · filed 2021-05-06 | -$2.24M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$1.46M derived: sum of 2 quarters · filed 2021-03-11 | -$3.10M derived: sum of 3 quarters · filed 2021-03-11 | -$2.65M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$4.25M derived: sum of 2 quarters · filed 2020-11-05 | -$3.80M 10-Q · filed 2020-11-05 | $2.40M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.19M 10-Q · filed 2020-08-06 | $5.01M derived: sum of 3 quarters · filed 2020-08-06 | $4.90M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $448.00K 10-Q · filed 2020-05-08 | $6.65M derived: sum of 2 quarters · filed 2020-05-08 | $6.54M derived: sum of 3 quarters · filed 2020-05-08 | $6.55M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $6.09M derived: sum of 2 quarters · filed 2020-03-16 | $6.10M derived: sum of 3 quarters · filed 2020-03-16 | $5.50M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$102.00K derived: sum of 2 quarters · filed 2019-11-04 | -$706.00K 10-Q · filed 2019-11-04 | $73.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$597.00K 10-Q · filed 2019-08-08 | $182.00K derived: sum of 3 quarters · filed 2019-08-08 | $283.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$604.00K 10-Q · filed 2019-05-09 | $175.00K derived: sum of 2 quarters · filed 2019-05-09 | $276.00K derived: sum of 3 quarters · filed 2019-05-09 | $102.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $779.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $880.00K derived: sum of 2 quarters · filed 2019-03-14 | $706.00K derived: sum of 3 quarters · filed 2019-03-14 | $575.00K 10-K · filed 2019-03-14 |
| 2017-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$73.00K derived: sum of 2 quarters · filed 2018-11-08 | -$204.00K 10-Q · filed 2018-11-08 | $3.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | -$174.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$305.00K 10-Q · filed 2018-08-09 | -$98.00K derived: sum of 3 quarters · filed 2019-03-14 | |
| 2017-03-31 | -$131.00K 10-Q · filed 2018-05-10 | $76.00K derived: sum of 2 quarters · filed 2019-03-14 | ||
| 2016-12-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $966.00K 10-K · filed 2019-03-14 | ||
| 2016-09-30 | $759.00K 10-Q · filed 2017-12-14 | |||
| 2015-12-31 | $280.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |